Allergan Receives FDA Approval for Acuvail Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Links shared publicly online about this topic.
- 1,876total visits
Allergan Receives FDA Approval for Acuvail Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Acuvail (ketorolac tromethamine ophthalmic solution) is used to treat pain and inflammation following cataract surgery. Includes Acuvail side effects, interactions and indications.
View full resource at drugs.com
Tags: Pain, Cataract, FDA, NSAIDs, Toradol, Allergan, Surgery
Most Recently Shared on July 24, 2009 at 12:17 am By:
FDA Approves Acuvail Ophthalmic Solution - http://bit.ly/q8Fek
Acuvail approved for post-cataract surgery pain and inflammation - MPR
empr.com — “The FDA has approved Acuvail (ketorolac tromethamine ophthalmic solution, from Allergan), a non-steroidal anti-inflammatory drug (NSAID), indicated for the treatment of pain and inflammation following cataract surgery.” View full resource at empr.com
Most Recently Shared on July 23, 2009 at 3:42 pm By:
MPR News: Acuvail approved for post-cataract surgery pain and inflammation: The FDA has approved Acuvai.. http://bit.ly/YXa8G
Advertisement
